Sintilimab in Cancer of Unknown Primary
Phase 2 Completed
10 enrolled 9 charts
CUPem
Phase 2 Completed
35 enrolled
CUPISCO
Phase 2 Completed
529 enrolled 16 charts
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
CUP-COMP
Completed
117 enrolled
OP-CUP
Phase NA Completed
30 enrolled
AGNOSTOS
Phase 2 Completed
57 enrolled
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
Phase NA Completed
41 enrolled
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Phase 1 Completed
230 enrolled
TOFFEE
Phase 2 Completed
59 enrolled
Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS
Phase 3 Completed
18 enrolled
APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors
Phase 1 Completed
30 enrolled
Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary
Phase 3 Completed
182 enrolled
Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
Phase 2 Completed
52 enrolled
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Phase 1 Completed
79 enrolled
GEFCAPI04
Phase 3 Completed
243 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
EPAC
Phase NA Completed
213 enrolled 20 charts
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
Completed
125 enrolled
Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
Phase 3 Completed
600 enrolled
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Completed
19 enrolled
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
Phase 2 Completed
12 enrolled
Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
Phase 2 Completed
31 enrolled 8 charts
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Phase 2 Completed
46 enrolled 13 charts
High-dose ICE With Amifostine
Phase 2 Completed
24 enrolled
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
Phase 1/2 Completed
36 enrolled
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Completed
98 enrolled
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
Phase 2 Completed
89 enrolled 12 charts
Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
Phase 2 Completed
60 enrolled 6 charts
Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
Completed
30 enrolled
Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
Phase 2 Completed
48 enrolled 6 charts
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer
Phase 3 Completed
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
Phase 2 Completed
Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
Phase 3 Completed
198 enrolled 7 charts
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
Phase 2 Completed
3 enrolled
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Phase 1 Completed
15 enrolled
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
24 enrolled
Cost-effectiveness Study of miRviewâ„¢ Mets in Patients With Cancer of Unknown Primary (CUP)
Completed
60 enrolled
Gemox as First and Second Line Therapy in Unknown Primary Cancer
Phase 2 Completed
29 enrolled
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled
Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors
Completed
136 enrolled
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
Phase 1 Completed
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Phase 1 Completed
20 enrolled
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
Phase 2 Completed